News | June 18, 2026
Bayer seals $300 million Perfuse deal
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments
The device screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
US formulations grew 11% to Rs. 564 crore as Alembic enters US branded pharmaceuticals market with launch of Pivya
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
The upgraded Rajajipuram centre now features enhanced retina services and advanced OCT technology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
